Cleared Traditional

K983309 - SENSITITRE 19 - 24 HOUR SUSCEPTIBILITY PLATES WITH LEVOFLOXACIN
(FDA 510(k) Clearance)

Dec 1998
Decision
84d
Days
Class 2
Risk

K983309 is an FDA 510(k) clearance for the SENSITITRE 19 - 24 HOUR SUSCEPTIBILITY PLATES WITH LEVOFLOXACIN. This device is classified as a Panels, Test, Susceptibility, Antimicrobial (Class II - Special Controls, product code LTT).

Submitted by Accumed Intl., Inc. (Westlake, US). The FDA issued a Cleared decision on December 14, 1998, 84 days after receiving the submission on September 21, 1998.

This device falls under the Microbiology FDA review panel. Regulated under 21 CFR 866.1640.

Submission Details

510(k) Number K983309 FDA.gov
FDA Decision Cleared Substantially Equivalent - Traditional 510(k) (SESE)
Date Received September 21, 1998
Decision Date December 14, 1998
Days to Decision 84 days
Submission Type Traditional
Review Panel Microbiology (MI)
Summary Statement

Device Classification

Product Code LTT — Panels, Test, Susceptibility, Antimicrobial
Device Class Class II - Special Controls
CFR Regulation 21 CFR 866.1640

Similar Devices — LTT Panels, Test, Susceptibility, Antimicrobial

All 49
MicroScan Dried Gram-Negative MIC/Combo Panels with Cefepime (CPE) (0.12-64 ?g/mL) (MicroScan)
K243804 · Beckman Coulter, Inc. · Aug 2025
MicroScan Dried Gram-Positive MIC/Combo Panels with Daptomycin (DAP) (0.06-32 ?g/mL)
K250036 · Beckman Coulter, Inc. · Aug 2025
MicroScan Dried Gram-Negative MIC/Combo Panels with Aztreonam (AZT) (0.5-64 ?g/mL)
K250084 · Beckman Coulter, Inc. · Jul 2025
MicroScan Dried Gram-Negative MIC/Combo Panels with Ceftazidime (Caz) (0.5-64 ?g/mL )
K202343 · Beckman Coulter, Inc. · Nov 2020
MicroScan Dried Gram-Negative MIC/Combo Panels with Meropenem (Mer) (0.004-32 ?g/mL)
K201423 · Beckman Coulter, Inc. · Jun 2020
MicroScan Dried Gram Negative MIC/Combo Panels with Ciprofloxacin (Cp) (0.004 - 8?g/mL)
K193536 · Beckman Coulter, Inc. · Mar 2020